These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12115514)

  • 1. Post-menopausal hormonal therapy and gallbladder cancer risk.
    Gallus S; Negri E; Chatenoud L; Bosetti C; Franceschi S; La Vecchia C
    Int J Cancer; 2002 Jun; 99(5):762-3. PubMed ID: 12115514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement treatment and breast cancer risk: an age-specific analysis.
    Tavani A; Braga C; La Vecchia C; Negri E; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 1997 Jan; 6(1):11-4. PubMed ID: 8993791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy and risk of colon and rectal cancer.
    Fernandez E; La Vecchia C; Braga C; Talamini R; Negri E; Parazzini F; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):329-33. PubMed ID: 9568789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and some risk factors for breast cancer among Slovenian postmenopausal women.
    Cerne JZ; Ferk P; Leskosek B; Gersak K
    Climacteric; 2011 Aug; 14(4):458-63. PubMed ID: 21294673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy and risk of lymphomas and myelomas.
    Altieri A; Gallus S; Franceschi S; Fernandez E; Talamini R; La Vecchia C
    Eur J Cancer Prev; 2004 Aug; 13(4):349-51. PubMed ID: 15554564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.
    Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR
    Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study.
    Douketis JD; Julian JA; Kearon C; Anderson DR; Crowther MA; Bates SM; Barone M; Piovella F; Turpie AG; Middeldorp S; van Nguyen P; Prandoni P; Wells PS; Kovacs MJ; MacGillavry MR; Costantini L; Ginsberg JS
    J Thromb Haemost; 2005 May; 3(5):943-8. PubMed ID: 15869589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Replacement therapy in menopause and risk for breast tumors].
    Franceschi S
    Ann Ist Super Sanita; 1997; 33(2):207-11. PubMed ID: 9470242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies.
    Fernandez E; Gallus S; Bosetti C; Franceschi S; Negri E; La Vecchia C
    Int J Cancer; 2003 Jun; 105(3):408-12. PubMed ID: 12704678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen therapy and risk of breast cancer in postmenopausal women: a case-control study and results of a multivariate analysis.
    Lumachi F; Frigo AC; Basso U; Tombolan V; Ermani M
    Menopause; 2010; 17(3):524-8. PubMed ID: 20130492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of breast cancer in post-menopausal women using hormone replacement therapy.
    Ratanawichitrasin A; Reansuwan W; Ratanawichitrasin S; Bhodhisuwan K; Kongpatanakul S
    J Med Assoc Thai; 2002 May; 85(5):583-9. PubMed ID: 12188389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy is associated with a decreased prevalence of peripheral arterial disease in postmenopausal women.
    Rockman CB; Maldonado TS; Jacobowitz GR; Adelman MA; Riles TS
    Ann Vasc Surg; 2012 Apr; 26(3):411-8. PubMed ID: 22285341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer.
    Fernandez E; La Vecchia C; D'Avanzo B; Franceschi S; Negri E; Parazzini F
    Br J Cancer; 1996 Jun; 73(11):1431-5. PubMed ID: 8645593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy.
    Hoffmeister M; Raum E; Krtschil A; Chang-Claude J; Brenner H
    Clin Pharmacol Ther; 2009 Oct; 86(4):416-24. PubMed ID: 19606090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy and risk of nonfatal acute myocardial infarction in Italy.
    Tavani A; Bertuzzi M; Gallus S; Negri E; La Vecchia C
    J Clin Epidemiol; 2005 Jul; 58(7):747-50. PubMed ID: 15939229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.
    Schwartz AG; Wenzlaff AS; Prysak GM; Murphy V; Cote ML; Brooks SC; Skafar DF; Lonardo F
    J Clin Oncol; 2007 Dec; 25(36):5785-92. PubMed ID: 18089876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone-related factors and post-menopausal onset depression: results from KNHANES (2010-2012).
    Jung SJ; Shin A; Kang D
    J Affect Disord; 2015 Apr; 175():176-83. PubMed ID: 25622021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.